Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation ; volume:40 ; number:1 ; day:23 ; month:2 ; year:2021 ; pages:1-16 ; date:12.2021
Journal of experimental & clinical cancer research ; 40, Heft 1 (23.2.2021), 1-16, 12.2021
- Creator
-
Kumar, Balawant
Ahmad, Rizwan
Giannico, Giovanna A.
Zent, Roy
Talmon, Geoffrey A.
Harris, Raymond C.
Clark, Peter E.
Lokeshwar, Vinata
Dhawan, Punita
Singh, Amar B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-021-01870-5
- URN
-
urn:nbn:de:101:1-2021041114375528133713
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kumar, Balawant
- Ahmad, Rizwan
- Giannico, Giovanna A.
- Zent, Roy
- Talmon, Geoffrey A.
- Harris, Raymond C.
- Clark, Peter E.
- Lokeshwar, Vinata
- Dhawan, Punita
- Singh, Amar B.
- SpringerLink (Online service)
Other Objects (12)
m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
Correction: m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis
Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions
CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal
LOXL1 modulates the malignant progression of colorectal cancer by inhibiting the transcriptional activity of YAP
FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway
Generierung und Charakterisierung Claudin 16 und Claudin 10 defizienter Mäuse
Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation
m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
Correction: m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis
Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions
CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal
LOXL1 modulates the malignant progression of colorectal cancer by inhibiting the transcriptional activity of YAP
FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway
Generierung und Charakterisierung Claudin 16 und Claudin 10 defizienter Mäuse
Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation
m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
Correction: m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis
Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions
CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal
LOXL1 modulates the malignant progression of colorectal cancer by inhibiting the transcriptional activity of YAP
FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway
Generierung und Charakterisierung Claudin 16 und Claudin 10 defizienter Mäuse